HOME >> BIOLOGY >> NEWS
Gene expression in liver tumors and patient prognosis

An analysis of the gene expression patterns of 91 unrelated liver tumors revealed two distinctive subclasses highly associated with patient survival, according to a new study published in the September 2004 issue of Hepatology.

Hepatology, the official journal of the American Association for the Study of Liver Diseases (AASLD), published by John Wiley & Sons, Inc., is available online via Wiley InterScience at http://www.interscience.wiley.com/journal/hepatology.

The study is among the first to explore the complete molecular pathogenesis of hepatocellular carcinoma (HCC). It identified expression profiles of a limited number of genes that accurately predicted length of patient survival and these findings may open the door to the development of more targeted therapies for liver cancer patients.

While gene technology has previously been applied to some specific aspects of liver cancer, researchers led by Dr. Snorri Thorgeirsson of the NIH's National Cancer Institute, sought to uncover molecular prognostic indices that could be applied to the overall patient population with HCC. They investigated variations in gene expression in HCC at diagnosis and compared them to patient survival over time.

The researchers examined 91 HCC tissues, 60 matched non-tumor surrounding liver tissues, and 18 normal liver samples. They isolated total RNA to derive complementary DNA and characterized each sample's gene expression profile. They applied three independent approaches for data analysis to uncover subclasses of HCC and the underlying biological differences between the subclasses.

The study yielded two distinct subclasses of HCC that were highly associated with patient survival and provided new molecular insight into the pathogenesis of HCC. Tumors from the low survival subclass had a strong cell proliferation and antiapoptosis gene expression signa
'"/>

Contact: David Greenberg
dgreenbe@wiley.com
201-748-6484
John Wiley & Sons, Inc.
13-Sep-2004


Page: 1 2

Related biology news :

1. A novel, safer strategy for regulating gene expression
2. Analysis of gene expression in lymphoid cells can determine lymphoma cancer
3. Jefferson scientists find gene expression pattern may predict behavior of leukemia
4. Outcome for acute lymphoblastic leukemia linked to gene expression patterns
5. Microarrays, key genome expression trackers, work better when probes are sequence-verified
6. Gene expression patterns may help predict risk and progression of prostate cancer
7. Altered expression of key developmental genes underlies evolution of butterfly wing patterns
8. New technique images gene expression in mice
9. Sex-specific differences in gene expression related to drug metabolism and hypertension
10. Gene expression ratio identifies risk of recurrence in breast cancer patients receiving tamoxifen
11. Gene expression profiling may predict head, neck cancer recurrence

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/28/2020)... and CAMBRIDGE, Mass. (PRWEB) , ... January 28, ... ... complex problems for life sciences companies and government agencies, announced that the firm ... hubs in the country. Tunnell’s Cambridge office will be in the Cambridge Innovation ...
(Date:1/27/2020)... ... 2020 , ... Cytonus Therapeutics Inc. today announced the appointment ... former senior management consultant at McKinsey & Company who holds three Harvard degrees. ... , “Chris Thorne has exceptional business acumen with a proven track record ...
(Date:1/24/2020)... ... January 24, 2020 , ... Worldwide Business with ... President Dr. Stanley Stanbridge and Vice President of Sales and Marketing Jeff Maier to ... Network as sponsored content on Sunday, Jan. 26, 2020 at 5:30 p.m. EST and ...
Breaking Biology News(10 mins):
(Date:1/27/2020)... ... January 27, 2020 , ... ... has secured financing from strategic investors led by Halma plc , a ... investors Sonion, TDF Ventures, GII LLC, and WSJ Joshua Fund. A representative from ...
(Date:1/23/2020)... ... January 22, 2020 , ... Ideal Implant CEO and President ... two recent North American investor forums specializing in medical advancements. New technology was ... Diagnostics Forum on November 21, 2019 in New York City, and the Aesthetic ...
(Date:1/22/2020)... ... 2020 , ... QCDx , a private biotech company that has developed ... announced the sale of the proprietary RareScope™ instrument to the Carole and Ray Neag ... cancer research. , “The RareScope can detect and isolate intact and live Circulating Tumor ...
(Date:1/8/2020)... ... 2020 , ... Anomet Products has introduced new ... in harsh environments inside or outside of the human body. , ... to achieve specific properties such as corrosion-resistance, biocompatibility, or operation at temperatures from ...
Breaking Biology Technology:
Cached News: